Immediate Impact
3 from Science/Nature 49 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Chiara Sarlo being referenced
Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa
2015
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chiara Sarlo | 291 | 89 | 142 | 24 | 389 | |
| Susan Russell | 157 | 52 | 92 | 26 | 413 | |
| Stefano Mancini | 153 | 104 | 54 | 25 | 394 | |
| P G Cachia | 211 | 82 | 26 | 21 | 359 | |
| Francesco Grimaldi | 161 | 73 | 33 | 29 | 449 | |
| Gordon B. Gale | 110 | 29 | 114 | 23 | 438 | |
| Hélène Haguet | 240 | 153 | 78 | 22 | 447 | |
| A. Franke | 132 | 114 | 28 | 27 | 353 | |
| D. K. Hossfeld | 198 | 128 | 80 | 22 | 402 | |
| B. Dörken | 108 | 64 | 34 | 22 | 381 | |
| Dragica Tomin | 331 | 105 | 64 | 35 | 410 |
All Works
Login with ORCID to disown or claim papers
Loading papers...